These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 31001)

  • 21. [Tardive dyskinesia after low doses of neuroleptics and attempts at treatment].
    Marsálek M
    Cesk Psychiatr; 1989 Apr; 85(2):100-5. PubMed ID: 2567213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spontaneous dyskinesia in the elderly and tardive dyskinesia of neuroleptics. A survey among 270 patients (author's transl)].
    Bourgeois M; Boueilh P; Tignol J
    Encephale; 1980; 6(1):37-9. PubMed ID: 6108850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of clozapine on neuroleptigenic extrapyramidal motor disturbances (author's transl)].
    Zander KJ; Rüther E
    Arzneimittelforschung; 1978; 28(9):1495-6. PubMed ID: 38808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of clozapine in severe tardive dyskinesia: a case report.
    Meltzer HY; Luchins DJ
    J Clin Psychopharmacol; 1984 Oct; 4(5):286-7. PubMed ID: 6149239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO
    Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
    Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tiapridal and alcoholic detoxication (author's transl)].
    Evens M
    Acta Psychiatr Belg; 1980; 80(2):149-55. PubMed ID: 7468277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medicolegal aspects of tardive dyskinesia in the United States].
    Wolf MA; Grunberg F; Garneau Y
    Encephale; 1988; 14(3):133-8. PubMed ID: 2900134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depot neuroleptic therapy: an underutilized treatment option.
    Glazer WM; Kane JM
    J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of sultopride in a case of neuroleptic-induced late dyskinesia].
    Leclere A; Plichart P
    Sem Hop; 1982 Nov; 58(42):2492-3. PubMed ID: 6130603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute neuroleptic-induced dyskinesia.
    Jeffries JJ
    Can J Psychiatry; 1983 Aug; 28(5):415. PubMed ID: 6138145
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcium therapy for neuroleptic-induced extrapyramidal symptoms.
    Jancar J
    Br J Psychiatry; 1988 Aug; 153():256-7. PubMed ID: 2908237
    [No Abstract]   [Full Text] [Related]  

  • 39. [Absorption, elimination and metabolism of a new neuroleptic agent (FLO 1347) in the rat dog and man (author's transl)].
    Strolin-Benedetti M; Donath A; Frigerio A; Morgan KT; Laville C; Malnoe A
    Ann Pharm Fr; 1978; 36(5-6):279-88. PubMed ID: 30386
    [No Abstract]   [Full Text] [Related]  

  • 40. [A study of a neurotropic product in a rehabilitation centre (author's transl)].
    Desnos J; Lilbert J
    Sem Hop; 1979 May 8-15; 55(17-18):869-70. PubMed ID: 39342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.